Physician profile
Asia Dutton
NPI 1457960635
$517.53
in general payments reported to CMS, 2019-2025
14 companies · $268 in 2025
The $268 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.00 · 2022: $30.68 · 2023: $87.30 · 2024: $109 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $198.27 | 2023-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $51.31 | 2023-2025 | Mounjaro, Jardiance |
| Lundbeck LLC | $36.18 | 2024-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $33.50 | 2024-2025 | Airsupra |
| Otsuka America Pharmaceutical, INC. | $30.84 | 2025 | Rexulti |
| Merck Sharp & Dohme LLC | $28.09 | 2025 | Lagevrio |
| Genentech USA, INC. | $22.00 | 2021 | |
| Abbvie INC. | $19.04 | 2023 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $18.00 | 2025 | Caplyta |
| Exact Sciences Corporation | $17.89 | 2025 | Cologuard Collection Kit |
| Teva Pharmaceuticals USA, INC. | $17.83 | 2022 | |
| Glaxosmithkline, LLC. | $16.69 | 2023 | Trelegy Ellipta |
| Tactile Systems Technology INC | $15.04 | 2025 | Nimbl, Flexitouch Plus |
| Biohaven Pharmaceutical Holding Company LTD. | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Asia Dutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.